Glucose variability assessed by low blood glucose index is predictive of hypoglycemic events in patientswith type 1 diabetes switched to pump therapy

Diabetes Care

Volumn 36, Issue 8, 2013, Pages 2148-2153

  Crenier, Laurent ^a   Abou Elias, Charlotte ^a   Corvilain, Bernard ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; DOSAGE SCHEDULE COMPARISON; FEMALE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; INFUSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MULTIPLE DAILY INJECTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; BLOOD; DIABETES MELLITUS, TYPE 1; INSULIN INFUSION; METABOLISM; MIDDLE AGED; REGRESSION ANALYSIS;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 84885984501     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2058     Document Type: Article

References (28)

1. Pickup JC. Management of diabetes mellitus: is the pump mightier than the pen? Nat Rev Endocrinol 2012;8:425-433
2. Hanaire H. External insulin pump treatment in the day-to-day management of diabetes: benefits and future prospectives. Diabetes Metab 2011;37(Suppl. 4):S40-S47
3. American Diabetes Association. Standards of medical care in diabetesd2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
4. Pickup JC,MattockMB, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002;324:705-708
5. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26: 1079-1087
6. Retnakaran R, Hochman J, DeVries JH, et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 2004;27:2590-2596
7. Jeitler K, Horvath K, Berghold A, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008;51:941-951
8. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765-774
9. Jacobsen IB, Henriksen JE, Hother-Nielsen O, Vach W, Beck-Nielsen H. Evidencebased insulin treatment in type 1 diabetes mellitus. Diabetes Res Clin Pract 2009;86: 1-10
10. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2009;94:729-740
11. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.CochraneDatabase SystRev 2010: CD005103
12. Monami M, Lamanna C, Marchionni N, Mannucci E. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a metaanalysis. Acta Diabetol 2010;47(Suppl. 1):77-81
13. Yeh HC, Brown TT, Maruthur N, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 2012;157:336-347
14. Lepore G, Dodesini AR, Nosari I, Trevisan R. Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients. Diabetes Care 2005;28:1834-1835
15. Retnakaran R, DeVries JH, Hanaire- Broutin H, Heine RJ, Melki V, Zinman B. Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c. Diabetes Care 2005; 28:1835-1836
16. Partridge H, Kerr D. Advantages of insulin pump therapy. DiabetMed 2009;26:1306
17. Frier BM. The incidence and impact of hypoglycemia in type 1 and type 2 diabetes. International Diabetes Monitor 2009;21:210-218
18. Frier BM. Morbidity of hypoglycemia in type 1 diabetes. Diabetes Res Clin Pract 2004;65(Suppl. 1):S47-S52
19. McCrimmon RJ, Frier BM. Hypoglycaemia, the most feared complication of insulin therapy. Diabete Metab 1994; 20:503-512
20. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-3176
21. Rodbard D. Clinical interpretation of indices of quality of glycemic control and glycemic variability. Postgrad Med 2011; 123:107-118
22. Rodbard D. Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes. J Diabetes Sci Tech 2007;1:62-71
23. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 1998;21:1870-1875
24. Kovatchev BP, Otto E, Cox D, Gonder- Frederick L, Clarke W. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006;29:2433-2438
25. McCall AL, Kovatchev BP. The median is not the only message: a clinician perspective on mathematical analysis of glycemic variability andmodeling in diabetes mellitus. J Diabetes Sci Tech 2009;3:3-11
26. Bruttomesso D, Crazzolara D, Maran A, et al. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008;25:326-332
27. Chimenti EM, de la Morena LH, Vaquero PM, Séez-de-Ibarra L, Domínguez MG, Sénchez LF. Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes. Diabetes Res Clin Pract 2010;90:e57-e59
28. Cox DJ, Kovatchev BP, Julian DM, et al. Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J Clin Endocrinol Metab 1994;79:1659-1662